What other stocks do shareholders of (RPTP) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (RPTP) investors own include BioCryst Pharmaceuticals (BCRX) , OPKO Health (OPK) , Freeport-McMoRan (FCX) , Novavax (NVAX) , Achillion Pharmaceuticals (ACHN) , Alnylam Pharmaceuticals (ALNY) , Arrowhead Pharmaceuticals (ARWR) , bluebird bio (BLUE) , Gilead Sciences (GILD) .

NASDAQ:RPTP

(RPTP) (RPTP) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free RPTP Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $9.00
▼
$9.00
50-Day Range: N/A
52-Week Range: $2.94
▼
$9.05

Volume: N/A
Average Volume: 1.42 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (RPTP) alerts:

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About (RPTP) Stock (NASDAQ:RPTP)

Raptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

RPTP Stock News Headlines

March 30, 2024 | msn.com

Key Insights into LAR-RPTP's Synaptic Regulation via Microexon Molecular Codes

March 29, 2024 | msn.com

Research suggests fine-tuning of specific excitatory synapse traits could lead to new brain disease treatments

April 16, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

August 17, 2023 | msn.com

Auckland Council bids to untangle transport from government

March 10, 2023 | msn.com

Amigo scrambles for survival as £45m emergency cash talks fail

February 23, 2023 | msn.com

The Arts Council of the Brazos Valley is hosting a Boots & BBQ Fundraiser to help the local community

January 29, 2023 | msn.com

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: Biotechnology
Current Symbol: NASDAQ:RPTP
CUSIP: 75382F10
CIK: 1070698
Web: www.horizonpharma.com
Phone: +1-415-4086200
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

RPTP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (RPTP) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (RPTP) investors own include BioCryst Pharmaceuticals (BCRX), OPKO Health (OPK), Freeport-McMoRan (FCX), Novavax (NVAX), Achillion Pharmaceuticals (ACHN), Alnylam Pharmaceuticals (ALNY), Arrowhead Pharmaceuticals (ARWR), bluebird bio (BLUE), Gilead Sciences (GILD).

This page (NASDAQ:RPTP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(RPTP) (RPTP) Stock Price, News & Analysis

About (RPTP) Stock (NASDAQ:RPTP)

RPTP Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

RPTP Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info